{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-002761","form_type":"8-K","ticker":"CPMV","cik":"0000836564","company_name":"Mosaic ImmunoEngineering Inc.","filed_at":"2024-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.114283+00:00","generated_at":"2026-06-03T06:02:39.909756+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Mosaic to acquire Oncotelic's clinical necroptosis cancer assets for up to $30M in stock","bullets":["Binding term sheet signed April 26, 2024; acquisition includes VDA necroptosis therapies and AI platform.","Initial $15M in common or preferred stock; milestone payments up to $15M more in shares.","Oncotelic to provide operational loan through June 1 and assist in raising $2M initial funding.","If funding fails, transaction may convert to reverse acquisition/merger; shareholder approval required.","Mosaic gains regulatory packages and access to Oncotelic's AI for immunotherapy combination discovery."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-002761","json":"https://secwatch.observer/filing/0001683168-24-002761.json","markdown":"https://secwatch.observer/filing/0001683168-24-002761.md","text":"https://secwatch.observer/filing/0001683168-24-002761.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/836564/000168316824002761/0001683168-24-002761-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/836564/000168316824002761/mosaic_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T06:02:39.909756+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}